Shareholding disclosure

HBM Bioventure AG

Declared position

4.99%

Threshold

Crossed upwards

Timeline

Published

30.06.2009

Transaction

24.06.2009

Transfer date

25.06.2009

Voting rights breakdown

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TA96T00021

Beneficial owner

HBM Bioventure AG

Declared address

HBM Bioventure AG, 6340 Baar

HBM BioVentures Ltd Cayman is totally controlled (100%) by HBM BioVentures AG

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

HBM Bioventure AG

Newron Pharmaceuticals S.p.A.30.06.2009TA96T00021

Disclosure summary

HBM Bioventure AG disclosed a holding in Newron Pharmaceuticals S.p.A. on the acquisition side, published by SIX Exchange Regulation on 30.06.2009, at 4.99% of voting rights. Notice category: Single shareholder.

Disclosed position

4.99%

Voting rights acquired

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

HBM Bioventure AG disclosed a holding in Newron Pharmaceuticals S.p.A., published on 30.06.2009.

Publication date30.06.2009

Transaction date24.06.2009

Transfer date25.06.2009

Issuing companyNewron Pharmaceuticals S.p.A.

Beneficial ownerHBM Bioventure AG

Declared addressHBM Bioventure AG, 6340 Baar

CategorySingle shareholder

Voting rights acquired4.99%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTA96T00021

Conditions

HBM BioVentures Ltd Cayman is totally controlled (100%) by HBM BioVentures AG

Source: SIX Exchange Regulation · Publication date: 30.06.2009

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open